“Digital PCR is definitely something that we can call on for analyzing liquid biopsy. It offers the greatest sensitivity for finding very small amounts of circulating tumor DNA.”
“Technologies are advancing rapidly. That’s what drives me and keeps me positive.”
“One of our top RNA biomarkers that we have identified in early cancer signature is not highly expressed. QIAcuity essentially gave us this 1000-fold sensitivity boost that we needed.”
“The combined analysis of both tumor- and immune-derived signals allows us to achieve the required sensitivity that we need for a screening test.”